Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Feb;30(2):386-90.
doi: 10.1128/jcm.30.2.386-390.1992.

Molecular epidemiology of Haemophilus influenzae type b in the Gambia

Affiliations

Molecular epidemiology of Haemophilus influenzae type b in the Gambia

H A Bijlmer et al. J Clin Microbiol. 1992 Feb.

Abstract

One hundred two invasive and 64 noninvasive isolates of Haemophilus influenzae were collected in the course of a 2-year prospective field study on the epidemiology of H. influenzae meningitis in The Gambia. The isolates were serotyped, biotyped, and subtyped by outer membrane protein (OMP) profile analysis (OMP subtyping). H. influenzae meningitis was found to be caused by serotype b (95%). In invasive disease, serotype a, although present in the throat of healthy children, caused only occasionally (5.9%) disease. The distribution of biotypes of H. influenzae appeared to be very similar to that found outside The Gambia. A distinct pattern of OMP subtypes, different from other parts of the world, is prevalent in H. influenzae type b (Hib) in The Gambia. OMP subtypes 2, 4, 5, 8, and 9 were observed to be predominant. These subtypes, except subtype 2, have not been described. L subtypes (subtypes 2, 4, and 8) were associated with invasive disease, whereas non-L subtypes (subtypes 5 and 9) were found more often in healthy carriers (P less than 0.001). A significant difference in geographical distribution was found in subtypes of noninvasive Hib strains (P less than 0.05). We conclude that in The Gambia H. influenzae invasive disease is caused mainly by type b strains with a limited number of OMP subtypes, which are different from the subtypes found elsewhere in the world. These data are important for the surveillance of Hib disease in developing countries and are baseline data for a Hib polyribosyl-ribitolphosphate-conjugated vaccine trial in The Gambia. Alternative Hib OMP vaccines should include a set of representative OMPs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Microb Pathog. 1990 Apr;8(4):279-88 - PubMed
    1. Trans R Soc Trop Med Hyg. 1989 Nov-Dec;83(6):831-5 - PubMed
    1. Lancet. 1985 Jun 8;1(8441):1343-4 - PubMed
    1. Lancet. 1987 Sep 19;2(8560):647-50 - PubMed
    1. J Infect Dis. 1986 Mar;153(3):448-61 - PubMed

Publication types

MeSH terms

Substances